UroGen Pharma URGN Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by UroGen Pharma in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is UroGen Pharma's compensation and benefits?
- UroGen Pharma (URGN) reported compensation and benefits of $9.84M in Q1 2026.
- How has UroGen Pharma's compensation and benefits changed year-over-year?
- UroGen Pharma's compensation and benefits increased by 41.2% year-over-year, from $6.97M to $9.84M.
- What is the long-term trend for UroGen Pharma's compensation and benefits?
- Over 5 years (2020 to 2025), UroGen Pharma's compensation and benefits has grown at a 7.2% compound annual growth rate (CAGR), from $9.55M to $13.52M.